{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:33:16Z","timestamp":1793356396232,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jchromb.2026.125320","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:44:33Z","timestamp":1790811873000},"page":"125320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metabolite-targeted LC\u2013HRMS quantification of emerging indazole-based synthetic cannabinoids in urine samples from an addiction treatment cohort"],"prefix":"10.1016","volume":"1284","author":[{"given":"Hacer","family":"Eroglu Icli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuna Guzide","family":"Yener Orum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cenk","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih Sultan","family":"Kazdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyhan","family":"Civek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Umut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Elci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Turkmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2017","key":"10.1016\/j.jchromb.2026.125320_bb0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/cpt.534","article-title":"Approaches, challenges, and advances in metabolism of new synthetic cannabinoids and identification of optimal urinary marker metabolites","volume":"101","author":"Diao","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2026.125320_bb0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11419-018-0415-z","article-title":"Pharmacological evaluation of new constituents of \u201cSpice\u201d: synthetic cannabinoids based on indole, indazole, benzimidazole and carbazole scaffolds","volume":"36","author":"Schoeder","year":"2018","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.jchromb.2026.125320_bb0015","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3390\/metabo13040576","article-title":"Study of the metabolic profiles of \u201cIndazole-3-Carboxamide\u201d and \u201cIsatin Acyl Hydrazone\u201d(OXIZID) synthetic cannabinoids in a human liver microsome model using UHPLC-QE Orbitrap MS","volume":"13","author":"Xiang","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.jchromb.2026.125320_bb0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/dta.2493","article-title":"Metabolic fate of the new synthetic cannabinoid 7\u2032N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometry","volume":"11","author":"Richter","year":"2019","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.jchromb.2026.125320_bb0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.forsciint.2017.01.023","article-title":"Identification of a new tert-leucinate class synthetic cannabinoid in powder and \u201cspice-like\u201d herbal incenses: methyl 2-[[1-(5-fluoropentyl) indole-3-carbonyl] amino]-3, 3-dimethyl-butanoate (5F-MDMB-PICA)","volume":"273","author":"Risseeuw","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jchromb.2026.125320_bb0030","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11419-020-00562-7","article-title":"Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, liver microsomes and confirmed using urine samples","volume":"39","author":"Leong","year":"2021","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.jchromb.2026.125320_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2023.117023","article-title":"Forensic drug screening by liquid chromatography hyphenated with high-resolution mass spectrometry (LC-HRMS)","volume":"162","author":"Heinsvig","year":"2023","journal-title":"TrAC-Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125320_bb0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11419-015-0270-0","article-title":"Comprehensive review of the detection methods for synthetic cannabinoids and cathinones","volume":"33","author":"Namera","year":"2015","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.jchromb.2026.125320_bb0045","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/medicina56080408","article-title":"UHPLC-HRMS and GC-MS screening of a selection of synthetic cannabinoids and metabolites in urine of consumers","volume":"56","author":"Pellegrini","year":"2020","journal-title":"Medicina"},{"key":"10.1016\/j.jchromb.2026.125320_bb0050","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/dta.3052","article-title":"Sensitive screening of synthetic cannabinoids using liquid chromatography quadrupole time\u2010of\u2010flight mass spectrometry after solid phase extraction","volume":"13","author":"Kleis","year":"2021","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.jchromb.2026.125320_bb0055","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1515\/cclm-2016-0831","article-title":"Immunoassay screening in urine for synthetic cannabinoids\u2013an evaluation of the diagnostic efficiency","volume":"55","author":"Franz","year":"2017","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"10.1016\/j.jchromb.2026.125320_bb0060","series-title":"Mass Spectrometry: Techniques and Applications. E-book","first-page":"347","author":"Pandey","year":"2025"},{"key":"10.1016\/j.jchromb.2026.125320_bb0065","article-title":"LC-HRMS suspect screening for expanded detection of (new) psychoactive substances in oral fluid: a practical approach for forensic casework","volume":"370","author":"Blanco-Ces","year":"2026","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jchromb.2026.125320_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462743","article-title":"Simultaneous screening of 239 synthetic cannabinoids and metabolites in blood and urine samples using liquid chromatography\u2013high resolution mass spectrometry","volume":"1663","author":"Shi","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125320_bb0075","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/03602532.2015.1029635","article-title":"Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices","volume":"47","author":"Castaneto","year":"2015","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jchromb.2026.125320_bb0080","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/biology11050796","article-title":"Detection of the synthetic cannabinoids AB-CHMINACA, ADB-CHMINACA, MDMB-CHMICA, and 5F-MDMB-PINACA in biological matrices: a systematic review","volume":"11","author":"Navarro-Tapia","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.jchromb.2026.125320_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2025.115793","article-title":"Analytical and toxicological evaluation of Xylazine adulteration: polydrug detection and in-silico assessment of 4-Hydroxy-Xylazine","volume":"218","author":"Arslan","year":"2025","journal-title":"Microchem. J."},{"key":"10.1016\/j.jchromb.2026.125320_bb0090","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jat\/bkt054","article-title":"Scientific Working Group for Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology","volume":"37","author":"Scientific Working Group for Forensic Toxicology","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2026.125320_bb0095","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/dta.2935","article-title":"The next generation of synthetic cannabinoids: detection, activity, and potential toxicity of pent\u20104en and but\u20103en analogues including MDMB\u20104en\u2010PINACA","volume":"13","author":"Krotulski","year":"2001","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.jchromb.2026.125320_bb0100","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/biology15080616","article-title":"A comprehensive HPLC-HRMS\/MS targeted screening method to detect 90 new psychoactive substances in oral fluid Samples","volume":"15","author":"Spinella","year":"2026","journal-title":"Biology"},{"key":"10.1016\/j.jchromb.2026.125320_bb0105","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/jat\/bkaa017","article-title":"In vitro phase I metabolism of the recently emerged synthetic MDMB-4en-PINACA and its detection in human urine samples","volume":"44","author":"Erol Ozturk","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2026.125320_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2023.109389","article-title":"Simultaneous detection of 87 synthetic cannabinoids and their metabolites in urine samples by UHPLC-MS\/MS and application to 109 authentic forensic cases","volume":"195","author":"Wu","year":"2023","journal-title":"Microchem. J."},{"key":"10.1016\/j.jchromb.2026.125320_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114985","article-title":"Metabolic profiles and screening tactics for MDMB-4en-PINACA in human urine and serum samples","volume":"220","author":"Gu","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125320_bb0120","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11419-022-00615-z","article-title":"Quantification of MDMB-4en-PINACA and ADB-BUTINACA in human hair by gas chromatography\u2013tandem mass spectrometry","volume":"40","author":"Wang","year":"2022","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.jchromb.2026.125320_bb0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11419-018-0448-3","article-title":"Sensitive quantification of BB-22 and its metabolite BB-22 3-carboxyindole, and characterization of new metabolites in authentic urine and\/or serum specimens obtained from three individuals by LC\u2013QTRAP-MS\/MS and high-resolution LC\u2013Orbitrap-MS\/MS","volume":"37","author":"Minakata","year":"2019","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.jchromb.2026.125320_bb0130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/15563650.2017.1287373","article-title":"Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015","volume":"55","author":"Abouchedid","year":"2017","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.jchromb.2026.125320_bb0135","first-page":"76","article-title":"Effect of laboratory confirmation of synthetic cannabinoid use on emergency department management and outcomes","volume":"5","author":"Ayd\u0131n","year":"2025","journal-title":"Int. J. Curr. Med. Biol. Sci."},{"key":"10.1016\/j.jchromb.2026.125320_bb0140","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Report on the risk assessment of a new psychoactive substance: methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate (MDMB-4en-PINACA) in accordance with Article 5c of Regulation (EC) No 1920\/2006 (as amended), Publications Office of the European Union, Luxembourg, 2020. doi: 10.2810\/135998."},{"key":"10.1016\/j.jchromb.2026.125320_bb0145","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/dta.3203","article-title":"The metabolism of the synthetic cannabinoids ADB\u2010BUTINACA and ADB\u20104en\u2010PINACA and their detection in forensic toxicology casework and infused papers seized in prisons","volume":"14","author":"Kronstrand","year":"2022","journal-title":"Drug Test Anal."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226004095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226004095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:34:05Z","timestamp":1793352845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023226004095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":29,"alternative-id":["S1570023226004095"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125320","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolite-targeted LC\u2013HRMS quantification of emerging indazole-based synthetic cannabinoids in urine samples from an addiction treatment cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125320"}}